...
首页> 外文期刊>American Journal of Physiology >Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases
【24h】

Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases

机译:基于GUT微生物组的临床诊断炎症肠疾病的监督机器学习

获取原文
获取原文并翻译 | 示例

摘要

Despite the availability of various diagnostic tests for inflammatory bowel diseases (IBD), misdiagnosis of IBD occurs frequently, and thus, there is a clinical need to further improve the diagnosis of IBD. As gut dysbiosis is reported in patients with IBD, we hypothesized that supervised machine learning (ML) could be used to analyze gut microbiome data for predictive diagnostics of IBD. To test our hypothesis, fecal 16S metagenomic data of 729 subjects with IBD and 700 subjects without IBD from the American Gut Project were analyzed using five different ML algorithms. Fifty differential bacterial taxa were identified [linear discriminant analysis effect size (LEfSe): linear discriminant analysis (LDA) score > 3] between the IBD and non-IBD groups, and ML classifications trained with these taxonomic features using random forest (RF) achieved a testing area under the receiver operating characteristic curves (AUC) of approx0.80. Next, we tested if operational taxonomic units (OTUs), instead of bacterial taxa, could be used as ML features for diagnostic classification of IBD. Top 500 high-variance OTUs were used for ML training, and an improved testing AUC of apprx0.82 (RF) was achieved. Lastly, we tested if supervised ML could be used for differentiating Crohn's disease (CD) and ulcerative colitis (UC). Using 331 CD and 141 UC samples, 117 differential bacterial taxa (LEfSe: LDA score > 3) were identified, and the RF model trained with differential taxonomic features or high-variance OTU features achieved a testing AUC > 0.90. In summary, our study demonstrates the promising potential of artificial intelligence via supervised ML modeling for predictive diagnostics of IBD using gut microbiome data. NEW & NOTEWORTHY Our study demonstrates the promising potential of artificial intelligence via supervised machine learning modeling for predictive diagnostics of different types of inflammatory bowel diseases using fecal gut microbiome data.
机译:尽管有各种炎症性肠病(IBD)的诊断试验,但IBD的误诊率仍然很高,因此,临床上仍需要进一步提高IBD的诊断水平。由于肠易激综合征患者出现肠道菌群失调,我们假设有监督机器学习(ML)可用于分析肠道菌群数据,用于预测诊断肠易激综合征。为了验证我们的假设,使用五种不同的ML算法分析了来自美国肠道项目的729名IBD受试者和700名非IBD受试者的粪便16S宏基因组数据。在IBD组和非IBD组之间确定了50种不同的细菌分类群[线性判别分析效应大小(LEfSe):线性判别分析(LDA)评分>3],并且使用随机森林(RF)利用这些分类特征训练的ML分类在APROX0的受试者操作特征曲线(AUC)下获得了一个测试区域。接下来,我们测试了操作分类单元(OTU)而不是细菌分类单元是否可以用作IBD诊断分类的ML特征。使用前500名高方差OTU进行ML训练,并改进了APPX0的测试AUC。达到82(RF)。最后,我们测试了监督的ML是否可以用于区分克罗恩病(CD)和溃疡性结肠炎(UC)。使用331个CD和141个UC样本,确定了117个差异细菌分类群(LEfSe:LDA评分>3),并且使用差异分类特征或高方差OTU特征训练的RF模型达到了测试AUC>0.90。总之,我们的研究表明,人工智能通过有监督的ML建模,利用肠道微生物组数据预测诊断IBD,具有很大的潜力。新的和值得注意的是,我们的研究通过有监督的机器学习建模,展示了人工智能在利用粪便-肠道微生物组数据预测诊断不同类型炎症性肠病方面的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号